Page last updated: 2024-10-24

chloroquine and Polycystic Ovarian Syndrome

chloroquine has been researched along with Polycystic Ovarian Syndrome in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kobayashi, M1
Yoshino, O1
Nakashima, A1
Ito, M1
Nishio, K1
Ono, Y1
Kusabiraki, T1
Kunitomi, C1
Takahashi, N1
Harada, M1
Hattori, K1
Orisaka, M1
Osuga, Y1
Saito, S1

Other Studies

1 other study available for chloroquine and Polycystic Ovarian Syndrome

ArticleYear
Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome.
    Molecular and cellular endocrinology, 2020, 05-15, Volume: 508

    Topics: Adult; Animals; Autophagy; Cattle; Chloroquine; Female; Humans; MAP Kinase Signaling System; Mitocho

2020